+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials

BMJ 317(7173): 1624-1629

Objective To determine whether intranasal corticosteroids are superior to oral H1 receptor antagonists (antihistamines) in the treatment of allergic rhinitis. Design Meta-analysis of randomised controlled trials comparing intranasal corticosteroids with oral antihistamines. Setting Randomised controlled trials conducted worldwide and published between 1966 and 1997. Subjects 2267 subjects with allergic rhinitis in 16 randomised controlled trials. Main outcome measures Nasal blockage, nasal discharge, sneezing, nasal itch, postnasal drip, nasal discomfort, total nasal symptoms, nasal resistance, and eye symptoms and global ratings. Outcomes measured on different scales were combined to determine pooled odds ratios (categorical outcomes) or standardised mean differences (continuous outcomes). Assessment of heterogeneity between studies, and subgroup analyses of eye symptoms, were undertaken. Results Intranasal corticosteroids produced significantly greater relief than oral antihistamines of nasal blockage (standardised mean difference -0.63, 95% confidence interval -0.73 to -0.53), nasal discharge (-0.5, -0.6 to -0.4), sneezing (-0.49, -0.59 to -0.39), nasal itch (-0.38, -0.49 to -0.21), postnasal drip (-0.24, -0.42 to -0.06), and total nasal symptoms (-0.42, -0.53 to -0.32), and global ratings gave an odds ratio for deterioration of symptoms of 0.26 (0.08 to 0.8). There were no significant differences between treatments for nasal discomfort, nasal resistance, or eye symptoms. The effects on sneezing, total nasal symptoms, and eve symptoms were significantly heterogeneous between studies. Other combined outcomes were homogeneous between studies. Subgroup analysis of the outcome of eye symptoms suggested that the duration of assessment (averaged mean score over the study period versus mean score at end of study period) might have accounted for the heterogeneity. Conclusion The results of this systematic review, together with data on safety and cost effectiveness, support the use of intranasal corticosteroids over oral antihistamines as first line treatment for allergic rhinitis.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 010874834

Download citation: RISBibTeXText

PMID: 9848901

DOI: 10.1136/bmj.317.7173.1624

Related references

Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Annals of Allergy, Asthma and Immunology 89(5): 479-484, 2002

Review: leukotriene-receptor antagonists are less effective than intranasal corticosteroids for allergic rhinitis. Acp Journal Club 141(2): 45-45, 2004

Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials. American Journal of Respiratory Medicine 2(1): 55-65, 2004

Intranasal corticosteroids compared with oral antihistamines in allergic rhinitis: A systematic review and meta-analysis. American Journal of Rhinology and Allergy 31(1): 19-28, 2017

Leukotriene receptor antagonist as add-on therapy to intranasal corticosteroids in the treatment of allergic rhinitis: a systematic review. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 29(3): 207-211, 2015

Acupoint herbal patching for allergic rhinitis: a systematic review and meta-analysis of randomised controlled trials. Clinical Otolaryngology 40(6): 551-568, 2016

Leukotriene receptor antagonists are not as effective as intranasal corticosteroids for managing nighttime symptoms of allergic rhinitis. Journal of Allergy and Clinical Immunology 116(2): 463-464, 2005

Efficacy of intranasal corticosteroids for the ocular symptoms of allergic rhinitis: A systematic review. Allergy and Asthma Proceedings 32(1): 22-35, 2011

Oral antihistamines for the symptom of nasal obstruction in persistent allergic rhinitis - a systematic review of randomized controlled trials. Clinical and Experimental Allergy 35(2): 207-212, 2005

Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials. Rhinology 53(4): 290-302, 2016

Clinical use of oral antihistamines and intranasal corticosteroids in patients with allergic rhinitis. Journal of Investigational Allergology and Clinical Immunology 21(5): 363-369, 2011

Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials. BMJ 314(7098): 1855-1859, 1997

Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. American Journal of Medicine 116(5): 338-344, 2004

Oral antihistamine/decongestant treatment compared with intranasal corticosteroids in seasonal allergic rhinitis. Clinical & Experimental Allergy. 25(1): 60-65, 1995

Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Annals of Allergy, Asthma & Immunology 101(6): 570-579, 2009